Q317 Market Recap Biosurgery Hemostats & Sealants: Supply Chain Disruptions
By Doug Devens, Senior Analyst Biosurgery
Surprisingly, the US market for Hemostats and Sealants was down vs Q217 and YoY, an anomaly from historic growth rates, primarily due to supply chain disruptions and softness in the thrombin hemostat segment.
The makeup of the market continues to evolve, as companies consider new indications for their products or bring products to market by capitalizing on trends...
Read entire Market Recap including news, data and analysis...*
*This article can only be viewed by SmartTRAK subscribers to this module.